BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30337516)

  • 1. Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation.
    Salvador NGA; Wee SY; Lin CC; Wu CC; Lu HI; Lin TL; Lee WF; Chan YC; Lin LM; Chen CL
    Ann Transplant; 2018 Oct; 23():733-743. PubMed ID: 30337516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living-donor liver transplantation in patients with concurrent active tuberculosis at transplantation.
    Lee YT; Hwang S; Lee SG; Kim KW; Choi NK; Park GC; Yu YD; Yoo JW; Kim WS; Shim TS
    Int J Tuberc Lung Dis; 2010 Aug; 14(8):1039-44. PubMed ID: 20626950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis.
    Wang YC; Salvador NG; Lin CC; Wu CC; Lin TL; Lee WF; Chan YC; Chen CL; Co JS; Encarnacion DD
    Biomed J; 2021 Dec; 44(6 Suppl 2):S162-S170. PubMed ID: 35300949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome.
    el-Agroudy AE; Refaie AF; Moussa OM; Ghoneim MA
    J Nephrol; 2003; 16(3):404-11. PubMed ID: 12832742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation.
    Chan AC; Lo CM; Ng KK; Chan SC; Fan ST
    Liver Int; 2007 Feb; 27(1):81-5. PubMed ID: 17241385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients.
    Imai S; Ito Y; Hirai T; Imai H; Ito I; Maekawa K; Chin K; Ichiyama S; Uemoto S; Mishima M
    Transpl Infect Dis; 2012 Feb; 14(1):9-16. PubMed ID: 22093707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
    Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience.
    Choudhary NS; Saraf N; Saigal S; Gautam D; Rastogi A; Goja S; Bhangui P; Srinivasan T; Yadav SK; Soin A
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29160909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
    Ha YE; Joo EJ; Park SY; Wi YM; Kang CI; Chung DR; Joh JW; Lee SK; Song JH; Peck KR
    Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
    Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
    Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
    Ghanekar A; Kashfi A; Cattral M; Selzner N; McGilvray I; Selzner M; Renner E; Lilly L; Levy G; Grant D; Greig P
    Transplant Proc; 2012 Jun; 44(5):1351-6. PubMed ID: 22664014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients.
    Saner FH; Olde Damink SW; Pavlakovic G; van den Broek MA; Rath PM; Sotiropoulos GC; Radtke A; Canbay A; Paul A; Nadalin S; Malagó M; Broelsch CE
    Transplantation; 2008 Jun; 85(11):1564-8. PubMed ID: 18551060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.
    Aguado JM; Herrero JA; Gavaldá J; Torre-Cisneros J; Blanes M; Rufí G; Moreno A; Gurguí M; Hayek M; Lumbreras C; Cantarell C
    Transplantation; 1997 May; 63(9):1278-86. PubMed ID: 9158022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country.
    Jambaldorj E; Han M; Jeong JC; Koo TY; Min SI; Song EY; Ha J; Ahn C; Yang J
    BMC Nephrol; 2017 Mar; 18(1):88. PubMed ID: 28292277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of tuberculosis after kidney transplantation in a developing country.
    Meinerz G; da Silva CK; Goldani JC; Garcia VD; Keitel E
    Transpl Infect Dis; 2016 Apr; 18(2):176-82. PubMed ID: 26820497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
    Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.